go to main content
Research MRI-guided Transurethral UltraSound Ablation

About this research group

This research group performs MRI-guided Transurethral UltraSound Ablation (TULSA) in the prostate.

Research group leader

prof. dr. Jurgen Fütterer

contact form

Aims

We perform MRI-guided Transurethral UltraSound Ablation (TULSA) in patients with localized prostate cancer. read more

Aims

We perform MRI-guided Transurethral UltraSound Ablation (TULSA) in patients with localized prostate cancer. We can either treat the whole prostate or only a specific area of the prostate. The ablation device is inserted in the patient’s urethra. During ablation high-intensity ultrasound waves will destroy the prostate tissue. The ablation process is continuously monitored by real-time MR temperature mapping. A special balloon is inserted in the rectum to cool the rectal wall and to prevent it from heating.
 

Research within MITeC

The TULSA treatment is performed at the MITeC facility, under real-time MRI guidance. So, during the treatment, the patient is in the MR-scanner. MITeC page

Connected to

Collaboration partner(s)